Navigation Links
WuXi PharmaTech Selected as One of the Top Ten Employer for New College Graduates in Pharmaceutical Industry in 2009
Date:8/14/2009

SHANGHAI, Aug. 14 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company, with operations in China and the United States, today announced that it had been selected as one of the top ten employers in the pharmaceutical industry in China in an online survey of new college graduates by China HR, a leading recruitment website in China. WuXi PharmaTech was the only contract research organization winning this award.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The survey captures the views of 210,000 Chinese students and covers approximately 630 universities and 3,800 businesses. The winning companies were selected on the basis of career development opportunities, enterprise capabilities, culture, and salary and benefits. Now in its sixth year, the survey has become the authoritative source of the opinions of new college graduates in China.

"College students in China have enormous potential, and it is essential that the best Chinese companies tap their talent," said Bob Zhu, Vice President of Human Resources and Corporate Communications. "At WuXi PharmaTech, our people are our most valuable asset and the source of our innovation. We strive to provide the college graduates that we hire with fulfilling careers in one of the world's most dynamic and important industries-pharmaceutical research and development."

WuXi PharmaTech has one of the best-educated and best-trained work forces in China. The company provides extensive training to our more than 4,000 employees, both in specific job skills and in more general areas, such as the English language and business management. The WuXi PharmaTech Science Seminar series invites the world's top scientific minds and leaders in the pharmaceutical industry to speak to our company's scientists, thereby enriching their work experience and enhancing their scientific knowledge.

    For more information, please contact:

    WuXi PharmaTech (Cayman) Inc.
     Ronald Aldridge (for investors)
     Director of Investor Relations
     Tel:   +1-201-585-2048
     Email: ir@wuxiapptec.com

     Stephanie Liu (for the media)
     Tel:   +86-21-5046-4362
     Email: pr@wuxiapptec.com

'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology
2. WuXi PharmaTech Files 2008 Annual Report on Form 20-F
3. WuXi PharmaTech Announces First-Quarter 2009 Results
4. WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance
5. Pharmatech Oncology Launches New Data Management Business Unit
6. WuXi PharmaTech Schedules Fourth Quarter 2008 Earnings Release on Thursday, March 26, 2009
7. WuXi PharmaTech Announces CFO Benson Tsang to Leave Company; COO Edward Hu Named Acting CFO
8. WuXi PharmaTech Honored on the Deloitte Technology Fast 500 Asia Pacific 2008 List for the Fifth Consecutive Year
9. WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board
10. WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference
11. WuXi PharmaTech Expands Collaboration for Fully Integrated Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying to ... rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive open ... resume and wondering if it’s as ready as you are for a new job ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... named the 2017 North American CAREGiverSM of the Year for her extraordinary compassion ... one of its 60,000 North American professional caregivers for the prestigious award each ...
(Date:4/27/2017)... ... 27, 2017 , ... Offering the purest product of its kind, Swissx Labs ... more potent than the market has seen before. Swissx uses proprietary strains of hemp ... patented chromatography process for extraction, to produce its CBD oil--maximizing its benefits for health ...
(Date:4/26/2017)... ... April 26, 2017 , ... Jump Technologies, Inc., ... announced it has completed a round of funding to accelerate its growth strategies. ... Black Granite Capital is a growth equity firm focused on investments in healthcare ...
(Date:4/26/2017)... , ... April 26, 2017 ... ... is thrilled to announce the ATA 2017 President’s Awards recipients, comprised of ... demonstrated superior healthcare delivery. , The ATA 2017 President’s Awards recognize ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... the InterContinental Hotel in Boston, Massachusetts ... present at 11:20 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  ...
(Date:4/20/2017)... 2017   ZappRx, Inc ., a digital health company ... today announced it closed $25 million in Series B funding ... based in Seattle that is part ... The Series B round included participation from SR One ... GV (formerly Google Ventures). As part of the ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
Breaking Medicine Technology: